Terumo Corporation

Diabeloop is a medical device company based in Grenoble, France, focused on innovating diabetes treatment through advanced technology. Founded in 2015, the company specializes in developing an AI-based closed-loop system that automates insulin delivery for individuals with type 1 diabetes. This system includes a blood sugar monitoring device that combines a glucose sensor, an insulin pump, and a smartphone application featuring an embedded algorithm. By continuously measuring glucose levels and delivering the appropriate insulin dosage, Diabeloop aims to reduce the mental burden on patients, allowing them to manage their condition more effectively and live their lives with greater ease.

Diabeloop is a medical device company based in Grenoble, France, focused on innovating diabetes treatment through advanced technology. Founded in 2015, the company specializes in developing an AI-based closed-loop system that automates insulin delivery for individuals with type 1 diabetes. This system includes a blood sugar monitoring device that combines a glucose sensor, an insulin pump, and a smartphone application featuring an embedded algorithm. By continuously measuring glucose levels and delivering the appropriate insulin dosage, Diabeloop aims to reduce the mental burden on patients, allowing them to manage their condition more effectively and live their lives with greater ease.

Orchestra BioMed, Inc. is a biomedical innovation company focused on developing high impact, high value, evidence-based therapeutic solutions for medical procedures that address major medical conditions. Its main focus is on developing new therapies for cardiovascular diseases which are the leading cause of death worldwide, taking the lives of 17.7 million people each year, or 31% of all global deaths according to the World Health Organization. It was founded in 2017 and is headquartered in New Hope, Pennsylvania.

Health Outcomes Sciences is dedicated to providing innovative IT solutions that improve the quality of healthcare delivery. We focus on translating the latest advances in clinical research into decision-support products and services for physicians and their patients, healthcare organizations, and other medical software developers. Their solutions empower users to see complex relationships between clinical variables—such as comorbidities, sociodemographic attributes, biochemical markers, and genomic determinants—and patient outcomes. Better understanding of these relationships allows patient care to be individualized in ways that previously could only be imagined. Their interdisciplinary team of physicians, outcomes researchers, and information technology experts pay special attention to creating user interfaces that are both intuitive and responsive and that readily integrate into the workflow of the researchers who develop risk models and the clinicians who use them.

Cuorips Inc. is a medical care company based in Chuo, Japan, with an additional office in Osaka. Founded in 2017, the company focuses on the research, development, and commercialization of iPS cell-derived cardiomyocyte sheets and various cell therapeutic products. Cuorips is involved in the manufacturing and sales of cellular and tissue-based products, as well as providing contract development and manufacturing services. The company aims to advance medical treatments through innovative cell products and therapies.

Quirem Medical B.V. is a medical device company based in Diepenveen, the Netherlands, founded in 2013. The company specializes in developing microspheres for Selective Internal Radiation Therapy (SIRT), specifically targeting liver malignancies. Its flagship product, QuiremSpheres, utilizes radioactive holmium-166 microspheres for radioembolization treatment, which allows for imaging and quantification to enhance patient selection, treatment planning, and verification. Quirem Medical aims to optimize treatment outcomes for patients with unresectable liver cancer by providing a complete solution that includes QuiremScout, QuiremSpheres, and dosimetry software known as Q-Suite. As of July 2020, Quirem Medical operates as a subsidiary of Terumo Corporation.

Orchestra BioMed, Inc. is a biomedical innovation company focused on developing high impact, high value, evidence-based therapeutic solutions for medical procedures that address major medical conditions. Its main focus is on developing new therapies for cardiovascular diseases which are the leading cause of death worldwide, taking the lives of 17.7 million people each year, or 31% of all global deaths according to the World Health Organization. It was founded in 2017 and is headquartered in New Hope, Pennsylvania.

Cuorips Inc. is a medical care company based in Chuo, Japan, with an additional office in Osaka. Founded in 2017, the company focuses on the research, development, and commercialization of iPS cell-derived cardiomyocyte sheets and various cell therapeutic products. Cuorips is involved in the manufacturing and sales of cellular and tissue-based products, as well as providing contract development and manufacturing services. The company aims to advance medical treatments through innovative cell products and therapies.

Vascutek is a designer and manufacturer specializing in products for vascular and cardiovascular clinicians. With over 35 years of experience, the company has developed a diverse range of products, including sealed woven and knitted polyester grafts for peripheral, abdominal, and cardiothoracic surgery, as well as ePTFE grafts and a custom AAA stent graft system. Vascutek focuses on addressing the needs of healthcare professionals in treating cardiovascular diseases. As a subsidiary of the Terumo Corporation of Japan, a leading global medical device company, Vascutek benefits from a robust support network and a commitment to innovation in medical technology.

ReThink Medical, Inc. is a medical device and digital health company based in San Francisco, California, specializing in the development of a wrist-worn monitoring device. Founded in 2010 and now a subsidiary of Terumo Corporation, ReThink Medical focuses on predicting and preventing heart failure hospitalizations through continuous physiological monitoring and advanced machine learning algorithms. Its flagship product, CorBand™, is designed to detect and notify users of worsening heart conditions weeks in advance, even before noticeable symptoms emerge. This proactive approach emphasizes compliance, simplicity, and accuracy, aiming to improve quality of life for patients while significantly reducing healthcare costs. The device monitors key indicators such as heartbeat rate and fluid status, enabling timely intervention and management of heart-related disorders.

Bolton Medical, Inc. specializes in developing endovascular solutions for the treatment of aortic conditions. The company manufactures and distributes thoracic and abdominal stent-graft systems designed to reduce vessel trauma and enhance navigation through the thoracic aorta. Its flagship product, relayplus, features a dual sheath delivery system that facilitates optimal aortic navigation and ensures predictable placement. Bolton Medical's innovations aim to provide effective treatment options for patients facing complex abdominal and aortic issues.

CaridianBCT is a global provider of technology, products and services in automated blood collection, therapeutic systems, whole blood processes and pathogen reduction technologies.